Eslam M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020;73(1):202–209. https://doi.org/10.1016/j.jhep.2020.03.039

Article  PubMed  Google Scholar 

Serfaty L, Lemoine M. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Diabetes Metab 2008;34(6 Part 2):634–637. https://doi.org/10.1016/S1262-3636(08)74597-X

Article  CAS  PubMed  Google Scholar 

Rinella ME, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023. https://doi.org/10.1016/j.jhep.2023.06.003

Article  PubMed  Google Scholar 

Ilyas F, et al. Increasing nonalcoholic fatty liver disease–related mortality rates in the United States from 1999 to 2022. Hepatol Commun 2023;7(7):e00207. https://doi.org/10.1097/hc9.0000000000000207

Article  PubMed  PubMed Central  Google Scholar 

Kaya E, Yilmaz Y. Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver. J Clin Transl Hepatol 2022;10(2):329–338. https://doi.org/10.14218/JCTH.2021.00178

Article  PubMed  Google Scholar 

Rocha R, Cotrim HP, Carvalho FM, Siqueira AC, Braga H, Freitas LA. Body mass index and waist circumference in non-alcoholic fatty liver disease. J Hum Nutr Diet 2005;18(5):365–370. https://doi.org/10.1111/j.1365-277X.2005.00634.x

Article  CAS  PubMed  Google Scholar 

Juanola O, Martínez-López S, Francés R, Gómez-Hurtado I. Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors. Int J Environ Res Public Health 2021;18(10):5227. https://doi.org/10.3390/ijerph18105227

Article  CAS  PubMed  PubMed Central  Google Scholar 

Valenti L, Ronzoni L. Genetics: a new clinical tool for the hepatologist. Liver Int 2022;42(4):724–726. https://doi.org/10.1111/liv.15205

Article  PubMed  Google Scholar 

Trépo E, Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol 2020;72(6):1196–1209. https://doi.org/10.1016/j.jhep.2020.02.020

Article  CAS  PubMed  Google Scholar 

Pelusi S, et al. Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: a case series. Liver Int 2022;42(4):864–870. https://doi.org/10.1111/liv.15185

Article  CAS  PubMed  Google Scholar 

Zheng M et al. Advancing diagnosis and management of liver disease in adults through exome sequencing. EBioMedicine 2023;95:104747. [Online]. Available: https://pan.ukbb.broadinstitute.org/

Caussy C, et al. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis. J Clin Invest 2017;127(7):2697–2704. https://doi.org/10.1172/JCI93465

Article  PubMed  PubMed Central  Google Scholar 

Loomba R, et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 2015;149(7):1784–1793. https://doi.org/10.1053/j.gastro.2015.08.011

Article  PubMed  Google Scholar 

Schwimmer JB, et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009;136(5):1585–1592. https://doi.org/10.1053/j.gastro.2009.01.050

Article  CAS  PubMed  Google Scholar 

Long MT, et al. Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring. Liver Int 2019;39(4):740–747. https://doi.org/10.1111/liv.13956

Article  PubMed  Google Scholar 

Dongiovanni P, et al. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med 2018;283(4):356–370. https://doi.org/10.1111/joim.12719

Article  CAS  PubMed  Google Scholar 

Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 2009;49(3):791–801. https://doi.org/10.1002/hep.22726

Article  PubMed  Google Scholar 

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2015. https://doi.org/10.1002/hep.28431/suppinfo

Article  PubMed  Google Scholar 

Kubiliun MJ, Cohen JC, Hobbs HH, Kozlitina J. Contribution of a genetic risk score to ethnic differences in fatty liver disease. Liver Int 2022;42(10):2227–2236. https://doi.org/10.1111/liv.15322

Article  PubMed  PubMed Central  Google Scholar 

Romeo S, Valenti L. African genetic ancestry and protection against fatty liver disease. Liver Int 2022;42:2122–2123

Article  PubMed  Google Scholar 

Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol 2018;68:268–279

Article  CAS  PubMed  Google Scholar 

Romeo S, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40(12):1461–1465. https://doi.org/10.1038/ng.257

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kozlitina J, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2014;46(4):352–356. https://doi.org/10.1038/ng.2901

Article  CAS  PubMed  PubMed Central  Google Scholar 

Speliotes EK, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011;7(3):e1001324. https://doi.org/10.1371/journal.pgen.1001324

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mancina RM, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of european descent. Gastroenterology 2016;150(5):1219–1230.e6. https://doi.org/10.1053/j.gastro.2016.01.032

Article  CAS  PubMed  Google Scholar 

Sookoian S, Pirola CJ, Valenti L, Davidson NO. Genetic pathways in nonalcoholic fatty liver disease: insights from systems biology. Hepatology 2020;72(1):330–346. https://doi.org/10.1002/hep.31229

Article  PubMed  Google Scholar 

Dongiovanni P, et al. PNPLA3 I148M polymorphism and progressive liver disease. World J Gastroenterol 2013;19(41):6969–6978. https://doi.org/10.3748/wjg.v19.i41.6969

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grimaudo S, et al. Association between PNPLA3 rs738409 C>G variant and liver-related outcomes in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2020;18(4):935–944.e3. https://doi.org/10.1016/j.cgh.2019.08.011

Article  CAS  PubMed  Google Scholar 

Li BT, et al. Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease. PLoS Genet 2020;16(8):e1008955. https://doi.org/10.1371/JOURNAL.PGEN.1008955

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prill S, et al. The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids. Sci Rep 2019;9(1):11585. https://doi.org/10.1038/s41598-019-47737-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smagris E, Gilyard S, BasuRay S, Cohen JC, Hobbs HH. Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins. J Biol Chem 2016;291(20):10659–10676. https://doi.org/10.1074/jbc.M116.719955

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu YL, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun 2014;5:4309. https://doi.org/10.1038/ncomms5309

Article  CAS  PubMed  Google Scholar 

Pelusi S, et al. Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease. Sci Rep 2019;9(1):3682. https://doi.org/10.1038/s41598-019-39998-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buch S, et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet 2015;47(12):1443–1448. https://doi.org/10.1038/ng.3417

Article  CAS  PubMed  Google Scholar 

Chen Y, et al. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. Nat Genet 2023. https://doi.org/10.1038/s41588-023-01497-6

Article  PubMed  PubMed Central